Editas Medicine Inc (EDIT) financials
Editas Medicine revenue and earnings by year
Editas Medicine's revenue was $40.5 million in the fiscal year to December 31, 2025, up 25.4% from the year before. Net income was -$160 million, -395.0% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 23.5% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 41 | 32 | 78 | 20 | 26 | 91 | 21 | 32 | 14 | 6 |
| Revenue growth | 25.4% | -58.6% | 296.3% | -22.8% | -71.8% | 341.9% | -35.7% | 132.6% | 126.8% | — |
| Operating income | -160 | -251 | -169 | -226 | -193 | -135 | -141 | -114 | -120 | -97 |
| Operating margin | -394.9% | -777.2% | -216.6% | -1146.3% | -756.1% | -148.6% | -686.4% | -356.1% | -873.6% | -1605.6% |
| Net income | -160 | -237 | -153 | -220 | -193 | -116 | -134 | -110 | -120 | -97 |
| Net margin | -395.0% | -733.7% | -196.1% | -1118.3% | -753.6% | -127.8% | -651.4% | -344.3% | -876.5% | -1605.5% |
| Diluted EPS | -$1.80 | -$2.88 | -$2.02 | -$3.21 | -$2.85 | -$2.00 | -$2.68 | -$2.33 | -$2.99 | -$3.09 |
| Free cash flow | -166 | -219 | -137 | -181 | -172 | -187 | -47 | -50 | -11 | -54 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open EDIT in Markets.
See also: EDIT returns
No forecast, no recommendation. This page describes Editas Medicine Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.